Accession | Title | Series type(s) | Organism(s) | Samples | GDS | Supplementary | Contact | Release date |
---|---|---|---|---|---|---|---|---|
Filter | human gammaherpesvirus 4 | |||||||
GSE115829 |
PARP1 Stabilizes CTCF Binding and Chromatin Structure to Maintain Epstein Barr Virus Latency Type
|
8 | Italo Tempera | Jun 27, 2018 | ||||
GSE198412 |
Nuclear lamina binds the EBV genome during latency and regulates viral gene expression [Hi-C]
|
|
4 | Priyankara J Wickramasinghe | Apr 08, 2022 | |||
GSE159834 |
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity [ChIP-Seq]
|
8 | Jozef Madzo | Nov 16, 2021 | ||||
GSE159837 |
The three-dimensional structure of Epstein-Barr virus genome varies by latency type and is regulated by PARP1 enzymatic activity
|
|
16 | Jozef Madzo | Nov 16, 2021 | |||
GSE198954 |
The Nuclear Lamina Binds the EBV Genome During Latency and Regulates Viral Gene Expression
|
5 | Jozef Madzo | Mar 18, 2022 | ||||
GSE245534 |
A distinct isoform of lymphoid enhancer binding factor 1 (LEF1) epigenetically restricts EBV reactivation to maintain viral latency
|
31 | Rona S. Scott | Dec 05, 2023 | ||||
GSE239992 |
The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC [HiChIP]
|
|
4 | Italo Tempera | Oct 11, 2023 | |||
GSE239995 |
The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC
|
|
29 | Italo Tempera | Oct 11, 2023 | |||
GSE42478 |
Defining a molecular roadmap of cellular reprogramming into iPS cells
|
|
61 | Ben S. Wittner | Dec 20, 2012 | |||
GSE221624 |
Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells [EBV WGS]
|
9 | Priyankara J Wickramasinghe | Dec 21, 2023 | ||||
GSE221625 |
Unstable EBV latency drives inflammation in multiple sclerosis patient derived spontaneous B cells
|
|
18 | Priyankara J Wickramasinghe | Dec 21, 2023 | |||
GSE234603 |
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer [ChIP-seq]
|
8 | Sarah Alp | Aug 04, 2023 | ||||
GSE234658 |
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer
|
16 | Sarah Alp | Jun 14, 2023 | ||||
GSE239645 |
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer [ATAC]
|
12 | Priyankara J Wickramasinghe | Aug 02, 2023 | ||||
GSE239767 |
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer [RNA]
|
18 | Priyankara J Wickramasinghe | Aug 02, 2023 | ||||
GSE239770 |
Decitabine disrupts EBV genomic epiallele DNA methylation patterns around CTCF binding sites to increase chromatin accessibility and lytic transcription in gastric cancer
|
30 | Priyankara J Wickramasinghe | Aug 02, 2023 | ||||
GSE239987 |
The three-dimensional structure of the EBV genome plays a crucial role in regulating viral gene expression in EBVaGC [ChIP-seq]
|
12 | Italo Tempera | Oct 11, 2023 | ||||
GSE19248 |
Performance Evaluation of Commercial miRNA Expression Array Platforms
|
28 | Sachin Sah | Mar 18, 2010 | ||||
GSE19693 |
STAR RNA-binding protein, Quaking, suppresses cancer via regulation of microRNA
|
48 | Hailei Zhang | Dec 30, 2009 | ||||
GSE25320 |
Characterisation of mRNA and microRNA in human mast cell exosomes and their transfer to other mast cells and blood CD34 progenitor cells
|
11 | Karin Ekström | Apr 16, 2012 |